BOULDER, Colo., October 4, 2018-- Front Range Biosciences®, a leading agricultural biotech company specializing in tissue culture propagation of high value crops, today announced that it has completed a $10 million Series A round of financing with participation from Phyto Partners, WelCan Capital, Salveo Capital, Cornerstone Opportunity Partners, Sand Hill Angels, Harvard Business School Alumni Angels of New York, New York Angels, Altitude Investment Management, and other new and returning investors. This marks the largest fundraising by a U.S. cannabis biotech company to date.